Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 47597
95 % 2 2 34378 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.6
PDBFlex
90 % 2 2 32903
70 % 2 2 29428
50 % 2 2 31532
40 % 2 2 23437
30 % 27 40 1224
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 73498
95 % 1 1 60567
90 % 335 573 4
70 % 1554 2488 2
50 % 3948 6398 1
40 % 3949 6399 1
30 % 3978 6466 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 73497
95 % 1 1 60566
90 % 1 1 57049
70 % 1883 3074 1
50 % 3949 6398 1
40 % 3950 6399 1
30 % 3979 6466 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 73500
95 % 2 2 40864 Flexibility: Low
Max RMSD: 1.1, Avg RMSD: 1.1
PDBFlex
90 % 2 2 30628
70 % 1884 3074 1
50 % 3950 6398 1
40 % 3951 6399 1
30 % 3980 6466 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 47598
95 % 9 10 5769 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 0.9
PDBFlex
90 % 336 573 4
70 % 1555 2488 2
50 % 3951 6398 1
40 % 3952 6399 1
30 % 3981 6466 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 6UCF 1 L N123-VRC34_pI4 light chain 9606
17 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
18 5YD4 1 A, C, E, G scFv 4B08 10090
19 5YD3 1 A, C, E, G scFv 4B08 10090
20 6OC7 1 H Heavy chain of HMP42 Fab 9606
21 6OC7 2 L Light chain for HMP42 Fab 9606
22 5UD9 1 H Fab heavy chain 9606
23 5UD9 2 L Light chain 9606
24 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
25 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
26 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
27 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
28 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
29 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
30 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
31 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
32 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
33 6MEE 2 B, D antibody HEPC74 Light Chain 9606
34 6BJZ 1 H 5c8 Fab Heavy chain 9606
35 6BJZ 2 L 5c8 Fab Light chain 9606
36 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
37 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
38 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
39 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
40 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
41 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
42 4XCF 1 L 4E10 Fab light chain 9606
43 4XCF 2 H 4E10 Fab heavy chain 9606
44 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
45 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
46 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
47 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
48 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
49 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
50 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
51 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
52 6UCE 1 L N123-VRC34_pI3 light chain 9606
53 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
54 5X08 1 H Fab 4E10 Heavy chain 9606
55 5X08 2 L Fab 4E10 Light chain 9606
56 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
57 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
58 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
59 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
60 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
61 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
62 6MEG 1 H antibody HEPC46 Heavy Chain 9606
63 6MEG 2 L antibody HEPC46 Light Chain 9606
64 5C2B 1 H scFv 3B4 9606
65 6O3K 1 L PGZL1.H4K3 light chain 9606
66 6O3K 2 H PGZL1.H4K3 heavy chain 9606
67 4XAW 1 L 4E10 Fab light chain 9606
68 4XAW 2 H 4E10 Fab heavy chain 9606
69 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
70 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
71 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
72 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
73 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
74 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
75 5UCB 1 H Fab Heavy Chain 9606
76 5UCB 2 L Fab Light Chain 9606
77 2VXV 1 H HUMAN IGG ABT-325 9606
78 2VXV 2 L HUMAN IGG ABT-325 9606
79 6QF9 1 A, B scFv 9606
80 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
81 4GXV 1 H, I Antibody 1F1, heavy chain 9606
82 4GXV 2 L, M Antibody 1F1, light chain 9606
83 2VXT 1 H MURINE IGG 125-2H 10090
84 2VXT 3 L MURINE IGG 125-2H 10090
85 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
86 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
87 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
88 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
89 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
90 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
91 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
92 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
93 5W24 1 L 5C4 Fab Light Chain 10090
94 5W24 2 H 5C4 Fab Heavy Chain 10090
95 4HPY 1 H CH59 Fab heavy chain 9606
96 4HPY 2 L CH59 Fab light chain 9606
97 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
98 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
99 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
100 4JG1 1 L Fab light chain 9606
101 4JG1 2 H Fab heavy chain 9606
102 6E65 1 L TB31F Fab light chain 9606
103 6E65 2 H TB31F Fab heavy chain 9606
104 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
105 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
106 5VF2 1 A scFv 2D10 10090
107 5I8C 1 A VRC34.01 Fab heavy chain 9606
108 5I8C 2 B VRC34.01 Fab light chain 9606
109 4O5L 1 L Fab F045-092 light chain 9606
110 4O5L 2 H Fab F045-092 heavy chain 9606
111 5MYX 1 A, C Fab c#24 light chain 10090
112 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
113 3IFL 1 L 12A11 FAB antibody light chain 10090
114 3IFL 2 H 12A11 FAB antibody heavy chain 10090
115 5WK2 1 L M116 LIGHT CHAIN 9606
116 5WK2 2 H M116 HEAVY CHAIN FD 9606
117 3PP4 1 H GA101 Fab heavy chain 10090
118 3PP4 2 L GA101 Fab light chain 10090
119 3KDM 1 A, L Immunoglobulin light chain 9606
120 3KDM 2 B, H Immunoglobulin heavy chain 9606
121 5NIV 1 A Light chain of 5D3 Fab 10090
122 5NIV 2 B Heavy chain of 5D3 Fab 10090
123 6UG7 1 L ch28/11 Fab light chain 10090
124 6UG7 2 H ch28/11 Fab heavy chain 10090
125 5N4J 1 L LIGHT CHAIN 9606
126 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
127 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
128 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
129 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
130 5X4G 1 A 6H8 Fab heavy chain 10090
131 5X4G 2 B 6H8 Fab light chain 10090
132 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
133 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
134 4PTU 1 A Antibody pn132p2C05, light chain 9606
135 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
136 4TPR 1 L If kappa light chain 10090
137 4TPR 2 H Fab heavy chain 10090
138 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
139 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
140 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
141 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
142 3IFN 1 H 12A11 FAB antibody heavy chain 10090
143 3IFN 2 L 12A11 FAB antibody light chain 10090
144 5U3P 1 H DH511.4 Fab Heavy Chain 9606
145 5U3P 2 L DH511.4 Fab Light Chain 9606
146 6BLA 1 H AMM01 Fab Heavy chain 9606
147 6BLA 2 L AMM01 Fab Light chain 9606
148 4TOY 1 H 35O22 Fab Heavy chain 9606
149 4TOY 2 L 35O22 Fab Light chain 9606
150 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
151 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
152 3NPS 2 B S4 FAB HEAVY CHAIN 9606
153 3NPS 3 C S4 FAB LIGHT CHAIN 9606
154 5I4F 1 A scFv 2D10 10090
155 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
156 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
157 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
158 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
159 5WN9 1 H scFv 2D10 9606
160 4XC3 1 L 4E10 Fab light chain 9606
161 4XC3 2 H 4E10 Fab heavy chain 9606
162 4M5Y 1 H, I Fab 5J8 heavy chain 9606
163 4M5Y 2 L, M Fab 5J8 light chain 9606
164 4TQE 1 L If kappa light chain 10090
165 4TQE 2 H Fab heavy chain 10090
166 5YY4 1 A scFv 4B08 10090
167 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
168 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
169 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
170 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
171 6Q19 1 L Fab lambda chain 9606
172 6Q19 2 H Fab heavy chain 9606
173 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
174 5VSI 2 L CH1/Ckappa Fab light chain 9606
175 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
176 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
177 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
178 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
179 5JXA 1 H VRC03 Heavy chain 9606
180 5JXA 2 L VRC03 Light chain 9606
181 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
182 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
183 6QCU 1 L Light chain 9606
184 6QCU 2 H Heavy chain 9606
185 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
186 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
187 3NTC 1 L Fab light chain 10090
188 3NTC 2 H Fab heavy chain 10090
189 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
190 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
191 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
192 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
193 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
194 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
195 6PBV 1 A, C Fab668 light chain 9606
196 6PBV 2 B, D Fab668 heavy chain 9606
197 6PZG 1 L NA-80 Fab light chain 9606
198 6PZG 2 H NA-80 Fab heavy chain 9606
199 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
200 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
201 6BE3 1 H Fab (F598) Heavy Chain 9606
202 6BE3 2 L Fab (F598) Light Chain 9606
203 4NWU 1 H APE1551 Ab Fab heavy chain 9606
204 4NWU 2 L APE1551 Ab Fab light chain 9606
205 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
206 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
207 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
208 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
209 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
210 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
211 5EWI 1 H VRC38.01 Heavy Chain 9606
212 5EWI 2 L VRC38.01 Light Chain 9606
213 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
214 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
215 5E2W 1 L AT8 LIGHT CHAIN 10090
216 5E2W 2 H AT8 HEAVY CHAIN 10090
217 5MYK 1 A Fab c#17 light chain 10090
218 5MYK 2 B Fab c#17 heavy chain 10090
219 4NZR 1 H PGT135 heavy chain Fab 9606
220 4NZR 2 L PGT135 light chain Fab 9606
221 5MYO 1 A, C Fab c#6 light chain 10090
222 5MYO 2 B, D Fab c#6 heavy chain 10090
223 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
224 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
225 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
226 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
227 5UEL 1 H 354NC102 Fab Heavy Chain 9606
228 5UEL 2 L 354NC102 Fab Light Chain 9606
229 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
230 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
231 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
232 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
233 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
234 5E2V 1 L AT8 LIGHT CHAIN 10090
235 5E2V 2 H AT8 HEAVY CHAIN 10090
236 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
237 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
238 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
239 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
240 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
241 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
242 5JUE 1 L light chain of UIC2 Fab 10090
243 5JUE 2 H heavy chain of UIC2 Fab 10090
244 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
245 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
246 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
247 5JR1 1 H 10E8 heavy chain 9606
248 5JR1 2 L 10E8 mature light chain 9606
249 6CA7 1 L PCT64_13C light chain 9606
250 6CA7 2 H PCT64_13C heavy chain 9606
251 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
252 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
253 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
254 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
255 6MVL 2 H Antibody Fab fragment heavy chain 9606
256 6MVL 3 L Antibody Fab fragment light chain 9606
257 5OB5 2 H fAb Heavy chain 9606
258 5OB5 3 L fAb Light chain 9606
259 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
260 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
261 5I66 1 A 8B6 antibody, heavy chain 10090
262 5I66 2 B 8B6 antibody, light chain 10090
263 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
264 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
265 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
266 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
267 6BZY 1 H 22D11 Heavy Chain 10090
268 6BZY 2 L 22D11 Light Chain 10090
269 3QQ9 1 C, L 101F LIGHT CHAIN 10090
270 3QQ9 2 D, H 101F HEAVY CHAIN 10090
271 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
272 5TKK 3 L mouse antibody vFP5.01 light chain 10090
273 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
274 5W6C 1 H UCA Fab heavy chain 9606
275 5W6C 2 L UCA Fab light chain 9606
276 5I1K 1 L FAB LIGHT CHAIN 9606
277 5I1K 2 H FAB HEAVY CHAIN 9606
278 3OZ9 1 L Fab NC-1 kappa light chain 10090
279 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
280 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
281 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
282 5V7U 1 L CBTAU-22.1 Fab light chain 9606
283 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
284 5UEA 1 A, H Fab Heavy Chain 9606
285 5UEA 3 B, L Fab Light Chain 9606
286 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
287 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
288 3G5Y 1 A 175 light chain 10090
289 3G5Y 2 B 175 heavy chain 10090
290 5NMV 1 L Fab light chain 10088
291 5NMV 2 H Fab heavy chain 10088
292 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
293 4N8C 2 L, M Light chain of monoclonal antibody 10090
294 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
295 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
296 4HGW 1 A Antibody Fab fragment, light chain 10090
297 4HGW 2 B Antibody Fab fragment, heavy chain 10090
298 1NLB 1 L antibody 19D9D6 light chain 10090
299 1NLB 2 H antibody 19D9D6 heavy chain 10090
300 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
301 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
302 3VFG 1 L 3F8 Light Chain 10090
303 3VFG 2 H 3F8 Heavy Chain 10090
304 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
305 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
306 3QRG 1 L Fab light chain 9606
307 3QRG 2 H Fab heavy chain Fd fragment 9606
308 5M6A 1 A, B, C, D Bence-Jones light chain 9606
309 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
310 4LLY 2 B, D light chain Clambda 9606
311 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
312 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
313 5EZI 1 H Fab c12 heavy chain 9606
314 5EZI 2 L Fab c12 Light chain 9606
315 4K23 1 H anti-uPAR antibody, heavy chain 10090
316 4K23 2 L anti-uPAR antibody, light chain 10090
317 3NCJ 1 L Fab15 Mut8 light chain 9606
318 3NCJ 2 H Fab15 Mut8 heavy chain 9606
319 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
320 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
321 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
322 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
323 5W05 1 L M59 FAB LIGHT CHAIN 10090
324 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
325 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
326 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
327 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
328 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
329 4M61 1 A, C Fab A52 light chain 10090
330 4M61 2 B, D Fab A52 heavy chain 10090
331 5YE3 1 B 2A7D9 VH CH1 chain 10090
332 5YE3 2 A 2A7D9 L chain 10090
333 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
334 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
335 1UM5 1 L Antibody 21H3 L chain 10090
336 1UM5 2 H Antibody 21H3 H chain 10090
337 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
338 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
339 4NWT 1 L APE1531 Ab Fab light chain 9606
340 4NWT 2 H APE1531 Ab Fab heavy chain 9606
341 3WHX 1 A mAb Fab H fragment 10090
342 3WHX 2 B mAb Fab L fragment 10090
343 3NA9 1 L Fab15 light chain 9606
344 3NA9 2 H Fab15 heavy chain 9606
345 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
346 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
347 6RCO 1 A, C R5.004 heavy chain 9606
348 6RCO 2 B, D R5.004 light chain 9606
349 6VBO 1 L DH813 light chain 9606
350 6VBO 2 H DH813 heavy chain 9606
351 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
352 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
353 4LRI 1 A, B MSL-109 Light Chain 9606
354 4LRI 2 C, P MSL-109 Heavy Chain 9606
355 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
356 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
357 4JN2 1 A, L anti dabigatran Fab 10090
358 4JN2 2 B, H anti dabigatran Fab 10090
359 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
360 4XBE 2 H 4E10 Fab heavy chain 9606
361 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
362 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
363 6BE2 1 H Fab (F598) Heavy Chain 9606
364 6BE2 2 L Fab (F598) Light Chain 9606
365 4JFZ 1 L Fab light chain 9606
366 4JFZ 2 H Fab heavy chain 9606
367 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
368 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
369 3WIF 1 A mAb Fab H fragment 10090
370 3WIF 2 B mAb Fab L fragment 10090
371 5U6A 1 A Light Chain 9606
372 5U6A 2 B Heavy Chain 9606
373 6K0Y 1 A Antibody Heavy Chain 9606
374 6K0Y 2 B Antibody Light Chain 9606
375 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
376 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
377 3MBX 1 L X836 LIGHT CHAIN 10090
378 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
379 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
380 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
381 6APC 1 H Epididymis luminal protein 214 9606
382 6APC 2 L IGL@ protein 9606
383 4HHA 1 A Fab KE5 Fab fragment KE5 9606
384 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
385 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
386 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
387 4RGO 2 H 14G8 heavy chain Fab 10090
388 4RGO 3 L 14G8 light chain Fab 10090
389 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
390 5GRY 1 A, G diabody 9606
391 5UEK 2 H Fab 12E Heavy Chain 9606
392 5UEK 3 L Fab 12E Light Chain 9606
393 3NAA 1 L Fab15 Mut5 light chain 9606
394 3NAA 2 H Fab15 Mut5 heavy chain 9606
395 1Q0X 1 L Fab 9B1, light chain 10090
396 1Q0X 2 H Fab 9B1, heavy chain 10090
397 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
398 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
399 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
400 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
401 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
402 5IK3 2 B, D 1E03 Fab fragment light chain 9606
403 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
404 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
405 5XLI 1 a, b FabL 10090
406 5XLI 2 c, d FabH 10090
407 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
408 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
409 6DC4 1 H Fab AM22 Heavy Chain 9606
410 6DC4 2 L Fab AM22 Light Chain 9606
411 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
412 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
413 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
414 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
415 4WUK 1 H CH65 heavy chain 9606
416 4WUK 2 L CH65 light chain 9606
417 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
418 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
419 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
420 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
421 5JOP 1 D, L Fab 14.22 light chain 10090
422 5JOP 2 E, H Fab14.22 heavy chain 10090
423 4HPO 1 H CH58 Fab heavy chain 9606
424 4HPO 2 L CH58 Fab light chain 9606
425 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
426 5UKN 2 L DH522UCA Fab fragment light chain 9544
427 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
428 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
429 5IT2 1 H heavy chain 9606
430 5IT2 2 L light chain 9606
431 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
432 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
433 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
434 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
435 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
436 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
437 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
438 5MO3 3 L Fab of monoclonal antibody, light chain 10090
439 6L8T 1 B, D, L Antibody light chain 9606
440 6L8T 2 A, C, H Antibody heavy chain 9606
441 5GZ0 1 A, C FM329 light chain 1383439
442 5GZ0 2 B, D FM329 heavy chain 1383439
443 6DW2 1 A 6078 Fab light chain 9606
444 6DW2 2 B 6078 Fab heavy chain 9606
445 6MG4 1 A, B JTO light chain 9606
446 6BQB 1 L MGG4 Fab light chain 9606
447 6BQB 2 H MGG4 Fab heavy chain 9606
448 4PUB 1 H DX-2930 HEAVY CHAIN 9606
449 4PUB 2 L DX-2930 LIGHT CHAIN 9606
450 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
451 6B14 2 L Light chain of Fab BL3-6S97N 10090
452 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
453 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
454 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
455 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
456 5GS3 1 A, H diabody protein 9606
457 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
458 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
459 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
460 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
461 5VKD 2 H Fab Heavy Chain 9606
462 5VKD 3 L Fab light chain 9606
463 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
464 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
465 5XHG 1 A, C polypeptide(L) 10090
466 5XHG 2 B, D polypeptide(H) 10090
467 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
468 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
469 3UYR 1 H antibody Fab heavy chain 10090
470 3UYR 2 L antibody Fab light chain 10090
471 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
472 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
473 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
474 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
475 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
476 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
477 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
478 3OAZ 2 K, L Fab 2G12, light chain 9606
479 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
480 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
481 1ZAN 1 L Fab AD11 Light Chain 10116
482 1ZAN 2 H Fab AD11 Heavy Chain 10116
483 6CJK 1 A, C Immunoglobulin Fab light chain 9986
484 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
485 4N0Y 1 H IGH526 Heavy Chain 9606
486 4N0Y 2 L IGH526 Light Chain 9606
487 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
488 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
489 6OTC 2 H sFab H3 heavy chain 32630
490 6OTC 3 L sFab H3 light chain 32630
491 6Q1G 1 L H1244 Fab lambda chain 9606
492 6Q1G 2 H H1244 Fab heavy chain 9606
493 5MTH 1 A, H antibody Fab heavy chain 10090
494 5MTH 2 B, L antibody Fab light chain 10090
495 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
496 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
497 6O26 1 A 3246 Fab heavy chain 9606
498 6O26 2 B 3246 Fab light chain 9606
499 1RZF 1 L Fab E51 light chain 9606
500 1RZF 2 H Fab E51 heavy chain 9606
501 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
502 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
503 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
504 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
505 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
506 4KTE 2 L GE148 Light Chain Fab 9544
507 5I8O 1 H HMM5 antibody heavy chain 9606
508 5I8O 2 L HMM5 antibody light chain 9606
509 4JG0 1 L Fab light chain 9606
510 4JG0 2 H Fab heavy chain 9606
511 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
512 4YGV 2 B, L aDabi-Fab2a light chain 9606
513 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
514 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
515 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
516 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
517 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
518 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
519 3EO0 1 A, C GC-1008 Fab Light Chain 10090
520 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
521 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
522 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
523 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
524 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
525 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
526 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
527 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
528 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
529 4FQI 3 H antibody CR9114 heavy chain Fab 9606
530 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
531 6S5A 2 H anti P329G LALA Fab heavy chain 10090
532 6S5A 3 L anti P329G LALA Fab light chain 10090
533 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
534 4JHA 2 L D25 light chain 9606
535 6B9Z 1 A Trastuzumab Fab light chain 10090
536 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
537 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
538 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
539 4PTT 1 A Antibody pn132p2C05, light chain 9606
540 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
541 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
542 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
543 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
544 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
545 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
546 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
547 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
548 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
549 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
550 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
551 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
552 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
553 4DGV 1 H HCV1 Heavy Chain Fab 9606
554 4DGV 2 L HCV1 Light Chain 9606
555 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
556 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
557 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
558 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
559 5TH2 1 A, C cetuximab Fab, light chain 10090
560 5TH2 2 B, D cetuximab Fab, heavy chain 10090
561 5I8K 1 L HHH1 Fab Light chain 9606
562 5I8K 2 H HHH1 Fab Heavy chain 9606
563 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
564 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
565 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
566 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
567 1YNL 1 L Ig gamma light chain 10090
568 1YNL 2 H Ig gamma heavy chain 10090
569 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
570 5EPM 2 B, F Antibody Fab fragment light chain 10090
571 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
572 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
573 3UMT 1 A scFv heavy chain and light chain 10090
574 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
575 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
576 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
577 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
578 6UC5 1 H Fab397 heavy chain 9606
579 6UC5 2 L Fab397 light chain 9606
580 4NUJ 1 A PGT152 light chain 9606
581 4NUJ 2 B PGT152 heavy chain 9606
582 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
583 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
584 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
585 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
586 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
587 3U2S 2 B, L PG9 light chain 9606
588 6PE7 1 H FAB Heavy Chain 9606
589 6PE7 2 L FAB Light chain 9606
590 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
591 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
592 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
593 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
594 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
595 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
596 4NUG 1 L PGT151 light chain 9606
597 4NUG 2 H PGT151 heavy chain 9606
598 3IU4 1 H chP3 Fab heavy chain 10090
599 3IU4 2 L chP3 Fab light chain 10090
600 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
601 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
602 6DC8 1 L IgG light chain 10090
603 6DC8 2 H IgG heavy chain 10090
604 6NYQ 1 L 1H3 Fab light chain 10090
605 6NYQ 2 H 1H3 Fab heavy chain 10090
606 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
607 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
608 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
609 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
610 6IAS 1 H Fab NKp46-1 heavy chain 32630
611 6IAS 2 L Fab NKp46-1 light chain 32630
612 1P7K 1 A, L antibody light chain FAB 10090
613 1P7K 2 B, H antibody heavy chain FAB 10090
614 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
615 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
616 3RVV 2 C 4C1 - light chain 10090
617 3RVV 3 D 4C1 - heavy chain 10090
618 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
619 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
620 3P0Y 2 H Fab DL11 heavy chain 9606
621 3P0Y 3 L Fab DL11 light chain 9606
622 4NPY 1 A, L germline PGT121 light chain Fab 9606
623 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
624 6ANA 2 H LL2 Fab Heavy Chain 10090
625 6ANA 3 L LL2 Fab Light Chain 10090
626 5IBU 1 B, L 6652 Light Chain 9606
627 5IBU 2 G, H 6652 Heavy Chain 9606
628 5VPL 2 C 4C1 - LIGHT CHAIN 10090
629 5VPL 3 D 4C1 - HEAVY CHAIN 10090
630 6AOD 1 A FXIa Antibody FAB Light Chain 9606
631 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
632 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
633 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
634 2YPV 2 H FAB 12C1 10090
635 2YPV 3 L FAB 12C1 10090
636 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
637 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
638 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
639 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
640 4JY5 1 L PGT122 light chain Fab 9606
641 4JY5 2 H PGT122 heavy chain Fab 9606
642 6ELE 1 A, H fAB heavy chain 9606
643 6ELE 2 B, L fAB light chain 9606
644 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
645 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
646 6B5R 1 H CIS42 Fab Heavy chain 9606
647 6B5R 2 L CIS42 Fab Light chain 9606
648 3NAC 1 L Fab15 Mut7 light chain 9606
649 3NAC 2 H Fab15 Mut7 heavy chain 9606
650 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
651 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
652 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
653 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
654 1Q72 1 L Fab M82G2, Light chain 10090
655 1Q72 2 H Fab M82G2, Heavy chain 10090
656 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
657 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
658 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
659 6MNQ 3 L Ab DH727.2 light chain 9544
660 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
661 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
662 4YHO 1 H aDabi-Fab3 heavy chain 9606
663 4YHO 2 L aDabi-Fab3 light chain 9606
664 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
665 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
666 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
667 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
668 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
669 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
670 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
671 4DGY 1 H HCV1 Heavy Chain Fab 9606
672 4DGY 2 L HCV1 Light Chain 9606
673 5EN2 1 A GD01 heavy chain 10090
674 5EN2 2 B GD01 light chain 10090
675 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
676 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
677 6P4Y 1 H 4A10 Fab heavy chain 10090
678 6P4Y 2 L 4A10 Fab light chain 10090
679 3MXW 2 L 5E1 light chain 9606
680 3MXW 3 H 5E1 heavy chain 9606
681 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
682 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
683 3EO9 1 L Efalizumab Fab fragment, light chain 9606
684 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
685 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
686 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
687 6N35 1 K, L Fab 2G12 light chain 9606
688 6N35 2 H, M Fab 2G12 heavy chain 9606
689 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
690 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
691 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
692 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
693 5WUV 1 L light chain 9606
694 5WUV 2 H heavy chain 9606
695 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
696 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
697 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
698 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
699 4JM4 1 H PGT 135 Heavy Chain Fab 9606
700 4JM4 2 L PGT 135 Light Chain Fab 9606
701 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
702 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
703 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
704 5YE4 2 B, D 1A9D7 L chain 10090
705 6B0G 1 C 1245 Antibody, Light Chain 9606
706 6B0G 2 D 1245 Antibody, Heavy Chain 9606
707 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
708 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
709 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
710 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
711 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
712 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
713 6D0X 1 A 2140 Antibody, heavy chain 9606
714 6D0X 2 B 1210 Antibody, light chain 9606
715 6BE4 1 H Fab (F598) Heavy Chain 9606
716 6BE4 2 L Fab(F598) Light Chain 9606
717 5TPP 1 L DH270.5 Fab heavy chain 9606
718 5TPP 2 H DH270.5 Fab light chain 9606
719 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
720 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
721 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
722 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
723 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
724 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
725 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
726 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
727 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
728 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
729 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
730 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
731 5TL5 1 L M2177 LIGHT CHAIN 10090
732 5TL5 2 H M2177 HEAVY CHAIN 10090
733 2FX7 1 L Fab 4E10 Light Chain 9606
734 2FX7 2 H Fab 4E10 Heavy Chain 9606
735 6O39 1 A Antibody F2.I Fab, Light chain 9606
736 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
737 5Y9K 1 L belimumab light chain 9606
738 5Y9K 2 H belimumab heavy chain 9606
739 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
740 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
741 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
742 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
743 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
744 6GLW 3 D, L Fab 1D11 - Light chain 9844
745 3WFH 1 A mAb Fab H fragment 10090
746 3WFH 2 B mAb Fab L fragment 10090
747 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
748 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
749 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
750 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
751 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
752 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
753 6GKU 2 H Fab 6F5 - Heavy Chain 9844
754 6GKU 3 L Fab 6F5 - Light chain 9844
755 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
756 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
757 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
758 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
759 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
760 5HI4 3 D, L CAT-2000 FAB light chain 9606
761 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
762 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
763 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
764 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
765 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
766 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
767 3RVW 2 C 4C1 - light chain 10090
768 3RVW 3 D 4C1 - heavy chain 10090
769 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
770 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
771 5XKU 2 B HNIgGA6 light chain 9606
772 5XKU 3 C HNIgGA6 heavy chain 9606
773 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
774 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
775 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
776 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
777 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
778 5HI5 3 D, L CAT-2000 light chain 9606
779 5JO5 1 A, C, E, H 10E8 gHV 9606
780 5JO5 2 B, D, F, L 10E8 gLV 9606
781 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
782 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
783 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
784 5CCK 2 L Antibody 3BC315 Fab light chain 9606
785 6RNN 1 C, L Immunoglobulin light chain 10090
786 6GXX 1 H FAB 1D9 heavy chain 10090
787 6GXX 2 L FAB 1D9 light chain 10090
788 6JP7 1 H immunoglobulin Fab heavy chain 9606
789 6JP7 2 L immunoglobulin Fab light chain 9606
790 5I76 1 A, C FM318_light_chain 1383439
791 5I76 2 B, D FM318_heavy_cahin 1383439
792 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
793 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
794 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
795 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
796 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
797 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
798 5I18 1 L FAB LIGHT CHAIN 9606
799 5I18 2 H FAB HEAVY CHAIN 9606
800 6QB3 2 X scFv55 9606
801 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
802 4JN1 2 L anti-dabigatran Fab1, light chain 10090
803 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
804 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
805 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
806 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
807 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
808 4G5Z 2 L canakinumab antibody fragment light chain 9606
809 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
810 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
811 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
812 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
813 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
814 2OK0 2 L Fab ED10 light chain 10090
815 2OK0 3 H Fab ED10 heavy chain 10090
816 3SOB 1 L antibody light chain 9606
817 3SOB 3 H antibody heavy chain 9606
818 6UG8 1 L ch28/11 Fab light chain 10090
819 6UG8 2 H ch28/11 Fab heavy chain 10090
820 6B5M 1 H CIS43 Fab Heavy chain 9606
821 6B5M 2 L CIS43 Fab Light chain 9606
822 5AWN 1 H Heavy chain of 3BC176 Fab 9606
823 5AWN 2 L Light chain of 3BC176 Fab 9606
824 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
825 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
826 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
827 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
828 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
829 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
830 5DR5 2 L AbD09097 Fab light chain 9606
831 6MG5 1 A, B Light chain JTO 9606
832 2IH3 1 A FAB Heavy Chain 10090
833 2IH3 2 B FAB Light Chain 10090
834 4KQ3 1 L CNTO3186 light chain Fab 9606
835 4KQ3 2 H CNTO3186 heavy chain Fab 9606
836 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
837 6AQ7 3 L POM6 FAB light CHAIN 10090
838 4JFX 1 A, L Fab light chain 9606
839 4JFX 2 B, H Fab heavy chain 9606
840 3SGE 1 I, L Light Chain 10090
841 3SGE 2 H, J Heavy Chain 10090
842 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
843 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
844 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
845 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
846 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
847 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
848 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
849 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
850 5FHB 1 H Antibody 100 Fab heavy chain 9606
851 5FHB 2 L Antibody 100 Fab light chain 9606
852 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
853 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
854 1JGU 1 L Antibody Light Chain 10090
855 1JGU 2 H Antibody Heavy Chain 10090
856 4I77 1 H Lebrikizumab heavy chain Fab 9606
857 4I77 2 L Lebrikizumab light chain Fab 9606
858 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
859 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
860 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
861 4O4Y 2 H 2095-2 heavy chain 9986
862 5OBF 1 H fAb Heavy chain 10090
863 5OBF 2 L fAb Light chain 10090
864 6QNK 1 A, C FAB light chain 10090
865 6QNK 2 B, D FAB heavy chain 10090
866 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
867 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
868 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
869 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
870 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
871 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
872 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
873 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
874 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
875 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
876 5MHE 1 L Fab-fragment 10090
877 5MHE 2 H Fab-fragment 10090
878 5YFI 1 L Light chain of Fab fragment 10090
879 5YFI 2 H Heavy chain of Fab fragment 10090
880 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
881 4GLR 3 I, K anti-ptau light chain light chain 9031
882 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
883 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
884 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
885 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
886 4HJG 1 A Trastuzumab light chain 9606
887 4HJG 2 B Trastuzumab heavy chain 9606
888 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
889 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
890 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
891 5I30 1 L Fab PL-2 light chain 10090
892 5I30 2 H Fab PL-2 heavy chain 10090
893 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
894 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
895 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
896 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
897 6CT7 1 B, L BIIB054 Fab light chain 9606
898 6CT7 2 A, H BIIB054 Fab heavy chain 9606
899 3FN0 1 L Fab Z13e1 light chain 9606
900 3FN0 2 H Fab Z13e1 heavy chain 9606
901 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
902 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
903 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
904 4YHI 2 B, L aDabi-Fab2a light chain 9606
905 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
906 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
907 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
908 4OSU 1 H SM5-1 Fab Heavy Chain 9606
909 4OSU 2 L SM5-1 Fab Light Chain 9606
910 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
911 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
912 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
913 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
914 1T2Q 1 L Fab NNA7 Heavy Chain 10090
915 1T2Q 2 H Fab NNA7 Light Chain 10090
916 6ELJ 1 A, H fAB heavy chain 9606
917 6ELJ 2 B, L fAB light chain 9606
918 4G6K 1 H heavy chain of gevokizumab antibody binding fragment